Viewing nowEsomeprazole Magnesium Trihydrate 20 mg Tablets
Esomeprazole Magnesium Trihydrate 21.69mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

MFDS item code 201804137 · Approved 2018.10.19 · Insurance code 640903720
Treatment and prevention of gastroesophageal reflux disease, gastrointestinal disorders (ulcers, H. pylori eradication, etc.), and Zollinger-Ellison syndrome
This medication is used for the treatment of erosive esophagitis caused by gastroesophageal reflux disease and to prevent recurrence. It is also effective in alleviating symptoms of gastroesophageal reflux disease without esophagitis. It is used in combination with antibiotics for the treatment and prevention of recurring peptic ulcers in patients with Helicobacter pylori infections. It helps in the short-term treatment of gastrointestinal symptoms caused by the use of non-steroidal anti-inflammatory drugs and in the treatment and prevention of associated gastric and duodenal ulcers. It is also indicated for the treatment of Zollinger-Ellison syndrome and used as maintenance therapy to prevent rebleeding in patients with gastric or duodenal ulcers at risk of bleeding. This medication has a wide range of applications in the treatment of various gastrointestinal disorders.
This drug should be swallowed with a liquid such as water; do not chew or crush it. Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Once symptoms are relieved, subsequent recurring symptoms are controlled by administering 20 mg once daily. In adults, 20 mg may be taken once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Administer this drug 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Clinical trials exceeding 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. According to clinical data, most patients can be controlled with a dose of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided into two doses. Administer 40 mg once daily for 4 weeks following intravenous induction to prevent rebleeding due to gastric or duodenal ulcers. Renal impairment: No dose adjustment is necessary. Since experience with administration to patients with severe renal failure is limited, administer with caution. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, do not exceed a dose of 20 mg of this drug. Older adults: No dose adjustment is necessary.
Adolescents 12 years of age and older — Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Adolescents 12 years of age and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Adolescents 12 years of age and older — Once symptoms are relieved, subsequent recurring symptoms are controlled by administering 20 mg once daily. Children under 12 years of age: There is no experience with administration of this drug to children under 12 years of age.
This medication should not be administered to patients with hypersensitivity to certain components or benzimidazole derivatives, or who have experienced such reactions in the past. It should also be avoided in patients taking certain antibiotics or some heart-related medications, nursing mothers, and patients with a history of myocardial infarction. This medication contains the dye Yellow No. 5, so patients who are allergic or hypersensitive to this component should use it cautiously. Although rare, various side effects such as blood-related abnormalities, allergic reactions, electrolyte imbalances, neurological symptoms, gastrointestinal disturbances, liver function abnormalities, skin rash may occur during use, so if symptoms appear, consultation with a physician is necessary. Regular checks for adverse reactions are essential during long-term use. This medication suppresses gastric acid secretion, reducing acidity in the stomach, which may increase the risk of bacterial infections and fractures, so patients at risk of osteoporosis should be particularly cautious. Long-term use may also lead to hypomagnesemia, necessitating magnesium level checks and possible supplementation if needed. This medication may interact with other medications, so if other medications are being taken, it is important to inform the physician or pharmacist, and it should be avoided with certain medications. Safety during pregnancy has not been fully established, so it should be used with caution, and it is advisable not to use it during nursing. There is no specific antidote for overdose, so treatment should be symptomatic and it should be stored out of reach of children.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, retrosternal pain, facial swelling, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, lethargy, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid enlargement, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal dysmotility, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, black stools, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, vomiting, ear pain, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia, hernia, rheumatoid polymyalgia, arthralgia, anorexia, apathy, increased appetite, confusion, exacerbation of depression, hypertonia, anxiety, sensory impairment, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremor, dizziness, visual field defects, paresthesia, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, hyposmia, ageusia, parageusia, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urination frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp, nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric mucosal polyp, hypocalcemia, hypokalemia, rhabdomyolysis, myalgia, asthenia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it is best to keep it at room temperature between 1 to 30 degrees Celsius. Storing it this way ensures the effectiveness of the medication is maintained safely.
Pale pink oval film-coated tablets
28 tablets per box [(7 tablets/Alu-Alu x 4)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 21.69mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.